The global psoriatic arthritis therapeutics drug market is expected to grow at a significant CAGR during the forecast period (2021-2027). Psoriatic arthritis is a form of arthritis that affects some people who have psoriasis, which is a condition that develops red patches on the skin with silvery scales. Most people develop psoriasis first and are later diagnosed with psoriatic arthritis. However, joint problems can sometimes begin before skin patches appear. This condition develops when the immune system begins to attack healthy cells and tissue. The abnormal immune response causes inflammation in the joints as well as overproduction of skin cells.
One of the major factors that can fuel the development of psoriatic arthritis is obesity. Hence, as the prevalence of obesity increases, the risk of psoriatic arthritis is expected to increase as well. Other factors like an unhealthy lifestyle with indulgence in alcohol and smoking can also be attributed as risk factors for the development of psoriatic arthritis. Moreover, the development of new therapeutic methods is also expected to drive the growth of this market.
To Request a Sample of our Report on Global Psoriatic Arthritis Therapeutics Drug Market: https://www.omrglobal.com/request-sample/psoriatic-arthritis-therapeutics-drug-market
The global psoriatic arthritis therapeutics drug market analysis includes some of the key market players such as Pfizer Inc., Eisai Inc., UCB Biosciences Inc., Sanofi S.A., Otsuka Pharmaceutical, Sumitomo Dainippon Pharma Co, and Johnson & Johnson, among others. To maintain a strong position in the market, these market players are adopting various strategic moves, such as product launches, partnerships, collaborations, and mergers and acquisitions.
Market Coverage
· The market number available for – 2020-2027
· Base year- 2020
· Forecast period- 2021-2027
· Segment Covered
· Regions Covered- Globally
· Competitive Landscape: NDPHARM, Wanhua Biochem, Jiangxi Haoran Bio-Pharma, Techpool, Microbic Biosystems Inc, and LIVZON among others.
(Get 15% Discount on Buying this Report)
A full Report of Global Psoriatic Arthritis Therapeutics Drug Market is Available at: https://www.omrglobal.com/industry-reports/psoriatic-arthritis-therapeutics-drug-market
Global Psoriatic Arthritis Therapeutics Drug Market by Segment
By Drug
• Nonsteroidal anti-inflammatory drug (NSAID)
• Disease-modifying antirheumatic drug (DMARD)
• Biologic drug
• Enzyme inhibitor
By Disease Type
• Asymmetric Psoriatic Arthritis
• Symmetric Psoriatic Arthritis
• Distal Interphalangeal Predominant (Dip) Psoriatic Arthritis
• Spondylitis
• Arthritis Mutilans
Global Psoriatic Arthritis Therapeutics Drug Market by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
